🇺🇸 FDA
Patent

US 9850300

Compositions and methods relating to inhibiting cancer cell growth and/or proliferation

granted A61KA61K2039/505A61K39/39558

Quick answer

US patent 9850300 (Compositions and methods relating to inhibiting cancer cell growth and/or proliferation) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Dec 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Dec 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K2039/505, A61K39/39558, A61K45/06, A61P